AmyCo: the amyloidoses collection

References

• Hazenberg BP. Amyloidosis: a clinical overview. Rheum Dis Clin North Am. 2013;39:323–345.
   PubMed Web of Science ®Google Scholar
• Winklhofer KF, Tatzelt J, Haass C. The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases. EMBO J. 2008;27:336–349.
   PubMed Web of Science ®Google Scholar
• Valastyan JS, Lindquist S. Mechanisms of protein-folding diseases at a glance. Dis Model Mech. 2014;7:9–14.
   PubMed Web of Science ®Google Scholar
• Agorogiannis EI, Agorogiannis GI, Papadimitriou A, et al. Protein misfolding in neurodegenerative diseases. Neuropathol Appl Neurobiol. 2004;30:215–224.
   PubMed Web of Science ®Google Scholar
• Soto C. Protein misfolding and disease; protein refolding and therapy. FEBS Lett. 2001;498:204–207.
   PubMed Web of Science ®Google Scholar
• Husby G, Sletten K. Chemical and clinical classification of amyloidosis 1985. Scand J Immunol. 1986;23:253–265.
   PubMed Web of Science ®Google Scholar
• Westermark P, Benson MD, Buxbaum JN, et al. A primer of amyloid nomenclature. Amyloid. 2007;14:179–183.
   PubMed Web of Science ®Google Scholar
• Benson MD, Buxbaum JN, Eisenberg DS, et al. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid. 2018;25:215–219.
   PubMed Web of Science ®Google Scholar
• Blancas-Mejia LM, Ramirez-Alvarado M. Systemic amyloidoses. Annu Rev Biochem. 2013;82:745–774.
   PubMed Web of Science ®Google Scholar
• Westermark P. Localized AL amyloidosis: a suicidal neoplasm?. Ups J Med Sci. 2012;117:244–250.
   PubMed Web of Science ®Google Scholar
• Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med. 1997;337:898–909.
   PubMed Web of Science ®Google Scholar
• Sipe JD, Benson MD, Buxbaum JN, et al. Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid. 2012;19:167–170.
   PubMed Web of Science ®Google Scholar
• Pepys MB. Amyloidosis [Research Support, Non-U.S. Gov’t Review]. Annu Rev Med. 2006;57:223–241.
   PubMed Web of Science ®Google Scholar
• Eisenberg D, Jucker M. The amyloid state of proteins in human diseases. Cell. 2012;148:1188–1203.
   PubMed Web of Science ®Google Scholar
• Glenner GG, Wong CW. Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984;120:885–890.
   PubMed Web of Science ®Google Scholar
• Alzheimer A, Stelzmann RA, Schnitzlein HN, et al. An English translation of Alzheimer’s 1907 paper, “Uber eine eigenartige Erkankung der Hirnrinde”. Clin Anat. 1995;8:429–431.
   PubMedGoogle Scholar
• Engedal K, Laks J. Towards a Brazilian dementia plan? Lessons to be learned from Europe. Dement Neuropsychol. 2016;10:74–78.
   PubMedGoogle Scholar
• Westermark P, Wernstedt C, O’Brien TD, et al. Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol. 1987;127:414–417.
   PubMed Web of Science ®Google Scholar
• Johnson KH, O’Brien TD, Betsholtz C, et al. Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus. N Engl J Med. 1989;321:513–518.
   PubMed Web of Science ®Google Scholar
• Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.
   PubMed Web of Science ®Google Scholar
• Nomenclature of amyloid and amyloidosis. WHO-IUIS Nomenclature Sub-Committee. Bull World Health Organ. 1993;71:105–112.
   PubMedGoogle Scholar
• Ogami Y, Takasugi M, Soejima M, et al. Waldenstrom’s macroglobulinemia associated with amyloidosis and crescentic glomerulonephritis. Nephron. 1989;51:95–98.
   PubMed Web of Science ®Google Scholar
• Tschang TP. Nodular malignant lymphoma and amyloidosis. A case report. Cancer. 1976;38:2192–2196.
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Brownstein MH. Localized amyloidosis in basal cell epitheliomas. Acta Derm Venereol. 1973;53:331–339.
   PubMed Web of Science ®Google Scholar
• Azzopardi JG, Lehner T. Systemic amyloidosis and malignant disease. J Clin Pathol. 1966;19:539–548.
   PubMed Web of Science ®Google Scholar
• Romero LS, Kantor GR, Levin MW, et al. Localized cutaneous amyloidosis associated with mycosis fungoides. J Am Acad Dermatol. 1997;37:124–127.
   PubMed Web of Science ®Google Scholar
• Ordi J, Grau JM, Junque A, et al. Secondary (AA) amyloidosis associated with Castleman’s disease. Report of two cases and review of the literature. Am J Clin Pathol. 1993;100:394–397.
   PubMed Web of Science ®Google Scholar
• Cohen AS, Frensdorff A, Lamprecht S, et al. A study of the fine structure of the amyloid associated with familial Mediterranean fever. Am J Pathol. 1962;41:567–578.
   PubMed Web of Science ®Google Scholar
• Fam AG, Lewis AJ, Cowan DH. Multiple myeloma and amyloid bone lesions complicating rheumatoid arthritis. J Rheumatol. 1981;8:845–850.
   PubMed Web of Science ®Google Scholar
• Alabi ZO, Ojo OS, Odesanmi WO. Secondary amyloidosis in chronic osteomyelitis. Int Orthop. 1991;15:21–22.
   PubMed Web of Science ®Google Scholar
• Yeoman W, Wilson JV. Rheumatoid arthritis and amyloid disease; report of a case. Br Med J. 1947;2:483–485.
   PubMed Web of Science ®Google Scholar
• Rowczenio DM, Noor I, Gillmore JD, et al. Online registry for mutations in hereditary amyloidosis including nomenclature recommendations. Hum Mutat. 2014;35:E2403–E2412.
   PubMed Web of Science ®Google Scholar
• Bodi K, Prokaeva T, Spencer B, et al. AL-Base: a visual platform analysis tool for the study of amyloidogenic immunoglobulin light chain sequences. Amyloid. 2009;16:1–8.
   PubMed Web of Science ®Google Scholar
• Bertram L, McQueen MB, Mullin K, et al. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet. 2007;39:17–23.
   PubMed Web of Science ®Google Scholar
• Lill CM, Roehr JT, McQueen MB, et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson’s disease genetics: the PDGene database. PLoS Genet. 2012;8:e1002548.
   PubMed Web of Science ®Google Scholar
• Yang JO, Kim WY, Jeong SY, et al. PDbase: a database of Parkinson’s disease-related genes and genetic variation using substantia nigra ESTs. BMC Genomics. 2009;10: S32.
   PubMedGoogle Scholar
• Cruts M, Theuns J, Van Broeckhoven C. Locus-specific mutation databases for neurodegenerative brain diseases. Hum Mutat. 2012;33:1340–1344.
   PubMed Web of Science ®Google Scholar
• WHO. International classification of diseases and related health problems, 10th revision. Geneva, Switzerland: World Health Organization; 1992.
   Google Scholar
• Rogers FB. Medical subject headings. Bull Med Libr Assoc. 1963;51:114–116.
   PubMedGoogle Scholar
• Amberger JS, Bocchini CA, Schiettecatte F, et al. OMIM.org: Online Mendelian Inheritance in Man (OMIM(R)), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 2015;43:D789–D798.
   PubMed Web of Science ®Google Scholar
• Coordinators NR. Database resources of the national center for biotechnology information. Nucleic Acids Res. 2017;45:D12–D17.
   PubMed Web of Science ®Google Scholar
• Varadi M, De Baets G, Vranken WF, et al. AmyPro: a database of proteins with validated amyloidogenic regions. Nucleic Acids Res. 2018;46:D387–D392.
   PubMed Web of Science ®Google Scholar
• Pundir S, Martin MJ, O’Donovan C. UniProt protein knowledgebase. Methods Mol Biol. 2017;1558:41–55.
   PubMedGoogle Scholar
• Valleix S, Verona G, Jourde-Chiche N, et al. D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile [Research Support, Non-U.S. Gov’t]. Nat Commun. 2016;7:10353.
   PubMed Web of Science ®Google Scholar
• Lavatelli F, di Fonzo A, Palladini G, et al. Systemic amyloidoses and proteomics: the state of the art. EuPA Open Proteom. 2016;11:4–10.
   PubMedGoogle Scholar
• Shoji M, Hirai S, Yamaguchi H, et al. Alpha 1-antichymotrypsin is present in diffuse senile plaques. A comparative study of beta-protein and alpha 1-antichymotrypsin immunostaining in the Alzheimer brain. Am J Pathol. 1991;138:247–257.
   PubMed Web of Science ®Google Scholar
• Miyazono M, Kitamoto T, Iwaki T, et al. Colocalization of prion protein and beta protein in the same amyloid plaques in patients with Gerstmann-Sträussler syndrome. Acta Neuropathol. 1992;83:333–339.
   PubMed Web of Science ®Google Scholar
• Nasr SH, Dasari S, Hasadsri L, et al. Novel type of renal amyloidosis derived from apolipoprotein-CII. J Am Soc Nephrol. 2017;28:439–445.
   PubMed Web of Science ®Google Scholar
• Franz M, Lopes CT, Huck G, et al. Cytoscape.js: a graph theory library for visualisation and analysis. Bioinformatics. 2016;32:309–311.
   PubMed Web of Science ®Google Scholar
• Misumi Y, Ando Y. [Classification of amyloidosis]. Brain Nerve. 2014;66:731–737.
   PubMedGoogle Scholar
• Westermark P, Benson MD, Buxbaum JN, et al. Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid. 2005;12:1–4.
   PubMed Web of Science ®Google Scholar
• Sipe JD, Benson MD, Buxbaum JN, et al. Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines. Amyloid. 2016;23:209–213.
   PubMed Web of Science ®Google Scholar
• Sipe JD, Benson MD, Buxbaum JN, et al. Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid. 2014;21:221–224.
   PubMed Web of Science ®Google Scholar
• Kaeser SA, Herzig MC, Coomaraswamy J, et al. Cystatin C modulates cerebral beta-amyloidosis. Nat Genet. 2007;39:1437–1439.
   PubMed Web of Science ®Google Scholar
• Levy E, Sastre M, Kumar A, et al. Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients. J Neuropathol Exp Neurol. 2001;60:94–104.
   PubMed Web of Science ®Google Scholar
• Martin-Rehrmann MD, Hoe HS, Capuani EM, et al. Association of apolipoprotein J-positive beta-amyloid plaques with dystrophic neurites in Alzheimer’s disease brain. Neurotox Res. 2005;7:231–242.
   PubMed Web of Science ®Google Scholar
• Finn RD, Coggill P, Eberhardt RY, et al. The Pfam protein families database: towards a more sustainable future. Nucleic Acids Res. 2016;44:D279–D285.
   PubMed Web of Science ®Google Scholar
• Balakrishnan R, Harris MA, Huntley R, et al. A guide to best practices for Gene Ontology (GO) manual annotation. Database (Oxford). 2013;2013:bat054.
   PubMed Web of Science ®Google Scholar
• Tsiolaki PL, Nastou KC, Hamodrakas SJ, et al. Mining databases for protein aggregation: a review. Amyloid. 2017;24:143–152.
   PubMed Web of Science ®Google Scholar
• Yates B, Braschi B, Gray KA, et al. Genenames.org: the HGNC and VGNC resources in 2017. Nucleic Acids Res. 2017;45:D619–D625.
   PubMed Web of Science ®Google Scholar
• Altschul SF, Gish W, Miller W, et al. Basic local alignment search tool. J Mol Biol. 1990;215:403–410.
   PubMed Web of Science ®Google Scholar
• Lipman DJ, Pearson WR. Rapid and sensitive protein similarity searches. Science. 1985;227:1435–1441.
   PubMed Web of Science ®Google Scholar
• Sevimoglu T, Arga KY. The role of protein interaction networks in systems biomedicine. Comput Struct Biotechnol J. 2014;11:22–27.
   PubMedGoogle Scholar